{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:08:23Z","timestamp":1782205703201,"version":"3.54.5"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Guidelines recommend adding intravenous (IV) metronidazole to oral vancomycin for fulminant Clostridioides difficile infection (CDI). In this study, we compared dual therapy with IV metronidazole and vancomycin vs vancomycin monotherapy. We assessed prevalence of use and effectiveness of dual therapy in nonfulminant and fulminant CDI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a 2-center retrospective study conducted from 2010 to 2018. Adult inpatients were included if they had a positive C. difficile polymerase chain reaction (PCR) performed on an unformed stool and received vancomycin within 2 days of testing. Patients were classified as having received dual therapy if IV metronidazole was given within the same time window, and otherwise classified as vancomycin monotherapy. The primary outcome was death or colectomy within 90 days after the index test. Logistic regression modeling was used to adjust for CDI severity and other established predictors of CDI outcomes. CDI recurrence was examined as a secondary outcome, adjusting for death as a competing risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The study included 2114 patients (dual therapy, 993; monotherapy, 1121); 23% met the primary outcome. There was no association between dual therapy and the primary outcome (adjusted odds ratio [aOR], 1.07; 95% confidence interval [CI], .79\u20131.45), which remained true when the analysis was restricted to patients with fulminant CDI (aOR, 1.17; 95% CI, .65\u20132.10). There was also no association between dual therapy and CDI recurrence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Dual therapy with IV metronidazole and vancomycin was common for nonfulminant and fulminant CDI but was not associated with improved outcomes compared with vancomycin alone.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciz1115","type":"journal-article","created":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T12:10:58Z","timestamp":1573301458000},"page":"2414-2420","source":"Crossref","is-referenced-by-count":25,"title":["Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in <i>Clostridioides difficile<\/i> Infection?"],"prefix":"10.1093","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4568-4026","authenticated-orcid":false,"given":"Ying","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Medicine, Columbia University Medical Center , New York, New York,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Schluger","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center , Valhalla, New York,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University Medical Center , New York, New York,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gomez-Simmonds","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University Medical Center , New York, New York,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojjat","family":"Salmasian","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Brigham and Women\u2019s Hospital , Boston, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E","family":"Freedberg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University Medical Center , New York, New York,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"2024111411412459000_CIT0001","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N Engl J Med"},{"key":"2024111411412459000_CIT0002","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N Engl J Med"},{"key":"2024111411412459000_CIT0003","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/1060028018757446","article-title":"The rise and fall of metronidazole for Clostridium difficile infection","volume":"52","author":"Chahine","year":"2018","journal-title":"Ann Pharmacother"},{"key":"2024111411412459000_CIT0004","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024111411412459000_CIT0005","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/jac\/dkp048","article-title":"In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile","volume":"63","author":"Hames","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"2024111411412459000_CIT0006","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1128\/JCM.02250-16","article-title":"Update on antimicrobial resistance in Clostridium difficile: resistance mechanisms and antimicrobial susceptibility testing","volume":"55","author":"Peng","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2024111411412459000_CIT0007","first-page":"371","article-title":"Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982\u20131991","volume":"15","author":"Olson","year":"1994","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2024111411412459000_CIT0008","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/cid\/civ409","article-title":"The addition of intravenous metronidazole to oral vancomycin is associated with improved mortality in critically Ill patients with Clostridium difficile infection","volume":"61","author":"Rokas","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2024111411412459000_CIT0009","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1128\/AAC.44.9.2419-2423.2000","article-title":"Effect of metronidazole on the pathogenicity of resistant Bacteroides strains in gnotobiotic mice","volume":"44","author":"Diniz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2024111411412459000_CIT0010","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJM200012283432604","article-title":"Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients","volume":"343","author":"Donskey","year":"2000","journal-title":"N Engl J Med"},{"key":"2024111411412459000_CIT0011","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nri3535","article-title":"Microbiota-mediated colonization resistance against intestinal pathogens","volume":"13","author":"Buffie","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"2024111411412459000_CIT0012","volume-title":"Flagyl (metronidazole) [prescribing information]","year":"2018"},{"key":"2024111411412459000_CIT0013","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/SLA.0b013e31822ade48","article-title":"Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease","volume":"254","author":"Neal","year":"2011","journal-title":"Ann Surg"},{"key":"2024111411412459000_CIT0014","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1093\/cid\/cis356","article-title":"Predictors of first recurrence of Clostridium difficile infection: implications for initial management","volume":"55","author":"Eyre","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2024111411412459000_CIT0015","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"2024111411412459000_CIT0016","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1136\/amiajnl-2013-001889","article-title":"Deriving comorbidities from medical records using natural language processing","volume":"20","author":"Salmasian","year":"2013","journal-title":"J Am Med Inform Assoc"},{"key":"2024111411412459000_CIT0017","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/jamasurg.2018.3174","article-title":"Development and validation of a prediction model for mortality and adverse outcomes among patients with peripheral eosinopenia on admission for Clostridium difficile infection","volume":"153","author":"Kulaylat","year":"2018","journal-title":"JAMA Surg"},{"key":"2024111411412459000_CIT0018","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A Proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2024111411412459000_CIT0019","article-title":"Effectiveness of intravenous metronidazole (M) in combination with oral vancomycin (V) for initial treatment of Clostridium difficile infection (CDI). Abstract\/poster from ID week","author":"Glick","year":"2013"},{"key":"2024111411412459000_CIT0020","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1093\/ofid\/ofy210.497","article-title":"Oral vancomycin plus intravenous metronidazole for severe Clostridium difficile infection in critically ill patients","volume":"5","author":"Vega","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2024111411412459000_CIT0021","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jhin.2012.12.019","article-title":"Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection","volume":"85","author":"Bass","year":"2013","journal-title":"J Hosp Infect"},{"key":"2024111411412459000_CIT0022","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/infdis\/jiv256","article-title":"Loss of microbiota-mediated colonization resistance to Clostridium difficile infection with oral vancomycin compared with metronidazole","volume":"212","author":"Lewis","year":"2015","journal-title":"J Infect Dis"},{"key":"2024111411412459000_CIT0023","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9343(81)90369-7","article-title":"Treatment of Clostridium difficile colitis and diarrhea with vancomycin","volume":"71","author":"Silva","year":"1981","journal-title":"Am J Med"},{"key":"2024111411412459000_CIT0024","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1128\/jcm.31.4.963-967.1993","article-title":"Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea","volume":"31","author":"Barbut","year":"1993","journal-title":"J Clin Microbiol"},{"key":"2024111411412459000_CIT0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2334-10-363","article-title":"Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection","volume":"10","author":"Gonzales","year":"2010","journal-title":"BMC Infect Dis"},{"key":"2024111411412459000_CIT0026","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gut.27.10.1169","article-title":"Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile","volume":"27","author":"Bolton","year":"1986","journal-title":"Gut"},{"key":"2024111411412459000_CIT0027","doi-asserted-by":"crossref","first-page":"248.e9","DOI":"10.1016\/j.cmi.2014.09.017","article-title":"Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes","volume":"21","author":"Freeman","year":"2015","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz1115\/30666039\/ciz1115.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/71\/9\/2414\/34676644\/ciz1115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/71\/9\/2414\/34676644\/ciz1115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:31:04Z","timestamp":1731587464000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/71\/9\/2414\/5623046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,11,12]]},"published-print":{"date-parts":[[2020,12,3]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz1115","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11,1]]},"published":{"date-parts":[[2019,11,12]]}}}